Obesity in renal transplantation:: Analysis of 2691 patients

被引:29
作者
Cofán, F
Vela, E
Clèries, M
机构
[1] OCATT, RMRC, Serv Catala Salut, Barcelona 08028, Spain
[2] Hosp Clin Barcelona, Renal Transplant Unit, Barcelona, Spain
关键词
D O I
10.1016/j.transproceed.2005.10.069
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. Obesity is a cardiovascular risk factor in renal transplantation (RT). The objective of this study was to analyze the prevalence of post-RT obesity and risk factors associated with its development. Patients and Methods. The study included all patients with a functioning renal transplant on December 31, 2003, who were residents of Catalonia, aged older than 14 years and who underwent transplantation between 1990 and 2003 (n = 2793); 102 patients (3.7%) were excluded due to lack of data for 1 or more study variables. Mean age was 53 +/- 14 years (range, 15-83) (61% men). Mean transplant duration was 63.0 +/- 44.5 months (range, 0-168). The chi-square test was used to compare proportions, analysis of variance (ANOVA) to compare mean values, and logistic regression to study risk factors for post-RT obesity. All data were taken from the Renal Registry of Catalonia (RMRC). Results. Among RT patients, 38% were overweight (body mass index [BMI], 25-29.9 kg/m(2)) and 16% were obese (BMI > 30). Prevalence of obesity was higher in women (21% vs 13%; P < .0001). Age was associated with obesity in RT patients aged 45-64 (20%) and 65-74 (18%) with respect to the group aged 15-44 years (9%) or > 74 years (13%) (P < .0001). A total of 26% of patients who were normal weight before RT (BMI, 20-24.9) became overweight post-RT and 6% developed obesity (P < .0001). Among patients who were overweight pre-RT, 68% persisted with post-RT excess weight and 16% progressed to obesity (P < .0001). In the multivariate study, significant risk factors for developing post-RT obesity included the following: female (relative risk [RR], 2.46; P < .0001), age (45-64 years; RR, 2.36; P < .0001; and 65-74 years; RR, 2.23; P = .002), high blood pressure (RR, 1.44; P = .03), duration of transplant (RR, 1.06; P < .0001), cardiomyopathy (RR, 1.51; P = .007), and, particularly, the presence of excess weight (RR, 2.69; P < .0001) and pre-RT obesity (RR, 59.02; P < .0001). Conclusions. There is a high prevalence of post-RT excess weight and obesity. Adequate control of cardiovascular risk in renal transplant recipients should also include strict measures to prevent and treat obesity.
引用
收藏
页码:3695 / 3697
页数:3
相关论文
共 7 条
[1]   Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant [J].
Alexander, JW ;
Goodman, HR ;
Gersin, K ;
Cardi, M ;
Austin, J ;
Goel, S ;
Safdar, S ;
Huang, SM ;
Woodle, ES .
TRANSPLANTATION, 2004, 78 (03) :469-474
[2]   Weight gain after renal transplantation is a risk factor for patient and graft outcome [J].
El-Agroudy, AE ;
Wafa, EW ;
Gheith, OE ;
El-Dein, ABS ;
Ghoneim, MA .
TRANSPLANTATION, 2004, 77 (09) :1381-1385
[3]   Obesity favors surgical and infectious complications after renal transplantation [J].
Espejo, B ;
Torrès, A ;
Valentín, M ;
Bueno, B ;
Andrés, A ;
Praga, M ;
Morales, JM .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) :1762-1763
[4]   Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index [J].
Glanton, CW ;
Kao, TC ;
Cruess, D ;
Agodoa, LYC ;
Abbott, KC .
KIDNEY INTERNATIONAL, 2003, 63 (02) :647-653
[5]   Obesity and kidney transplantation [J].
Jindal, RM ;
Zawada, ET .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (06) :943-952
[6]   Morbid obesity is not a contraindication to kidney transplantation [J].
Marks, WH ;
Florence, LS ;
Chapman, PH ;
Precht, AF ;
Perkinson, DT .
AMERICAN JOURNAL OF SURGERY, 2004, 187 (05) :635-638
[7]   Nutrition for the post-renal transplant recipients [J].
Martins, C ;
Pecoits, R ;
Riella, MC .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) :1650-1654